What is the difference between ALPRAZOLAM ODT C-IV and TEMAZEPAM?

ALPRAZOLAM ODT C-IV and TEMAZEPAM are both Benzodiazepines, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Alprazolam ODT C-IV the same as Temazepam?

No. Alprazolam ODT C-IV (ALPRAZOLAM ODT C-IV) and Temazepam (TEMAZEPAM) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ALPRAZOLAM ODT C-IV or TEMAZEPAM?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ALPRAZOLAM ODT C-IV to TEMAZEPAM?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ALPRAZOLAM ODT C-IV vs TEMAZEPAM

Compare ALPRAZOLAM ODT C-IV (Alprazolam ODT C-IV) and TEMAZEPAM (Temazepam) — clinical data, side effects, and patient experiences.

ALPRAZOLAM ODT C-IV

Alprazolam ODT C-IV · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets

USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term

placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets

USP are also indicated for the treatment of panic disorder

OralTablet

TEMAZEPAM

Temazepam, Restoril · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

INDICATIONS AND USAGE Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia

OralTablet

Quick Comparison

ALPRAZOLAM ODT C-IVTEMAZEPAM

Drug Class

Benzodiazepine

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALPRAZOLAM ODT C-IV

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

TEMAZEPAM

Fatigue

1-10%

Drug Not Working

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Insomnia

1-10%

Dizziness

1-10%

FDA Warnings

ALPRAZOLAM ODT C-IV

1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone
Advise both patients and caregivers about the risks of respiratory depression and sedation when alprazolam is used with opioids

TEMAZEPAM

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death
Follow patients for signs and symptoms of respiratory depression and sedation ( see WARNINGS and PRECAUTIONS )
The use of benzodiazepines, including temazepam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death
Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes

Clinical Trial Data

No head-to-head clinical studies found for ALPRAZOLAM ODT C-IV vs TEMAZEPAM.

ALPRAZOLAM ODT C-IV vs TEMAZEPAM: What You Should Know

Key Differences

Both ALPRAZOLAM ODT C-IV and TEMAZEPAM belong to the Benzodiazepine class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ALPRAZOLAM ODT C-IV carries 4 FDA warnings. TEMAZEPAM carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

LORAZEPAM vs TEMAZEPAM→CLONAZEPAM vs TEMAZEPAM→DIAZEPAM vs TEMAZEPAM→ALPRAZOLAM vs TEMAZEPAM→OXAZEPAM vs TEMAZEPAM→CLOBAZAM vs TEMAZEPAM→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALPRAZOLAM ODT C-IV: DailyMed label · FAERS adverse events · ClinicalTrials.gov
TEMAZEPAM: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ALPRAZOLAM ODT C-IV vs TEMAZEPAM

Compare ALPRAZOLAM ODT C-IV (Alprazolam ODT C-IV) and TEMAZEPAM (Temazepam) — clinical data, side effects, and patient experiences.

ALPRAZOLAM ODT C-IV

Alprazolam ODT C-IV · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets

USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term

placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets

USP are also indicated for the treatment of panic disorder

OralTablet

TEMAZEPAM

Temazepam, Restoril · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

INDICATIONS AND USAGE Temazepam capsules are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia

OralTablet

Quick Comparison

ALPRAZOLAM ODT C-IVTEMAZEPAM

Drug Class

Benzodiazepine

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALPRAZOLAM ODT C-IV

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

TEMAZEPAM

Fatigue

1-10%

Drug Not Working

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Insomnia

1-10%

Dizziness

1-10%

FDA Warnings

ALPRAZOLAM ODT C-IV

1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone
Advise both patients and caregivers about the risks of respiratory depression and sedation when alprazolam is used with opioids

TEMAZEPAM

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death
Follow patients for signs and symptoms of respiratory depression and sedation ( see WARNINGS and PRECAUTIONS )
The use of benzodiazepines, including temazepam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death
Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes

Clinical Trial Data

No head-to-head clinical studies found for ALPRAZOLAM ODT C-IV vs TEMAZEPAM.

ALPRAZOLAM ODT C-IV vs TEMAZEPAM: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.